Jill Gaidos, MD
Associate Professor of Medicine (Digestive Diseases); Director of Clinical Research, Yale Inflammatory Bowel Disease Program; Vice Chief of Clinical Research, Digestive Diseases
Research & Publications
Biography
News
Research Summary
Dr. Gaidos is the PI for numerous industry-sponsored and investigator-initiated IBD clinical trials. She has research interests in patient outcomes, preventive care and pregnancy in patients with IBD.
Coauthors
Selected Publications
- Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel DiseaseMcMillan C, Li D, Mohamed G, Alsadoun D, Almohsen L, Gaidos J, Proctor D, Al-Bawardy B. Longer Colonoscopy Withdrawal Time Is Associated With the Detection of Visible Dysplasia in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2024, 6: otae020. PMID: 38585555, PMCID: PMC10998460, DOI: 10.1093/crocol/otae020.
- Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel DiseaseSahyoun L, Fetene J, McMillan C, Protiva P, Al Bawardy B, Gaidos J, Proctor D. Impact of COVID-19 Treatment on Real-World Outcomes in Inflammatory Bowel Disease. Digestive Diseases And Sciences 2024, 69: 1654-1660. PMID: 38466459, DOI: 10.1007/s10620-024-08355-3.
- S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive AnalysisSahyoun L, McMillan C, Fetene J, Protiva P, Al-Bawardy B, Gaidos J, Proctor D. S1000 Exploring the Influence of COVID-19 Treatment on Real-World Outcomes in IBD Patients: A Comprehensive Analysis. The American Journal Of Gastroenterology 2023, 118: s757-s757. DOI: 10.14309/01.ajg.0000953640.32433.d2.
- S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center StudyAlmomen H, Alomar I, McMillan C, Gaidos J, Proctor D, AlMutairdi A, Al-Bawardy B. S1006 Comparison of Upadacitinib Induction in Tofacitinib Exposed and Naïve Patients With Inflammatory Bowel Disease: A Real World Multi-Center Study. The American Journal Of Gastroenterology 2023, 118: s761-s762. DOI: 10.14309/01.ajg.0000953664.83573.de.
- S940 Histologic Healing in Crohn's Disease Is Not Associated With Long Term OutcomesLevine L, Liang Y, McMillan C, Jain D, Mohamed G, Almohsen L, Alsadoun D, Gaidos J, Proctor D, Al-Bawardy B. S940 Histologic Healing in Crohn's Disease Is Not Associated With Long Term Outcomes. The American Journal Of Gastroenterology 2023, 118: s704-s705. DOI: 10.14309/01.ajg.0000953400.77190.37.
- S947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel DiseaseVasudevan J, Damianos J, DiVincenzo C, Gaidos J, Burgermaster M, Feagins L. S947 Why IBD Patients Aren’t Eating ‘an Apple a Day:’ Understanding Dietary Fiber Avoidance in Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2023, 118: s710-s711. DOI: 10.14309/01.ajg.0000953428.77556.69.
- S1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical CentersChavez V, Vasudevan J, Ochi M, Sahyoun L, Kogan L, Anand T, Gaidos J, Feagins L. S1007 No Impact of Primary Language on Treatment and Outcomes for Patients With Inflammatory Bowel Disease in 2 Academic Medical Centers. The American Journal Of Gastroenterology 2023, 118: s762-s763. DOI: 10.14309/01.ajg.0000953668.62572.df.
- S1009 Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapy for Biologics Given Via Infusion CentersXiao K, Gottesman S, Nguyen H, Hernandez E, Anand T, Saweris E, Jaganathan P, Jafri F, Davis J, Tong K, Gaidos J, Feagins L. S1009 Higher Rates of Delay in Starting Advanced Inflammatory Bowel Disease Therapy for Biologics Given Via Infusion Centers. The American Journal Of Gastroenterology 2023, 118: s764-s765. DOI: 10.14309/01.ajg.0000953676.10735.44.
- AGA Clinical Practice Update on Management of Ostomies: CommentaryHedrick T, Sherman A, Cohen-Mekelburg S, Gaidos J. AGA Clinical Practice Update on Management of Ostomies: Commentary. Clinical Gastroenterology And Hepatology 2023, 21: 2473-2477. PMID: 37498275, DOI: 10.1016/j.cgh.2023.04.035.
- Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical PracticeGaidos J, Bawardy B, Farraye F, Regueiro M. Use of Standardized Inflammatory Bowel Disease Endoscopy Scores in Clinical Practice. Crohn's & Colitis 360 2023, 5: otad037. PMID: 37559746, PMCID: PMC10407976, DOI: 10.1093/crocol/otad037.
- Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative ColitisSharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. Early Flexible Sigmoidoscopy Improves Clinical Outcomes in Acute Severe Ulcerative Colitis. Crohn's & Colitis 360 2023, 5: otad032. PMID: 37323477, PMCID: PMC10263117, DOI: 10.1093/crocol/otad032.
- Mo1714 DIETARY FIBER INTAKE ASSOCIATED WITH REDUCED IBD DISEASE ACTIVITYVasudevan J, Larson D, Damianos J, Shori C, DiVincenzo C, Ishola Y, Gaidos J, Burgermaster M, Feagins L. Mo1714 DIETARY FIBER INTAKE ASSOCIATED WITH REDUCED IBD DISEASE ACTIVITY. Gastroenterology 2023, 164: s-876-s-877. DOI: 10.1016/s0016-5085(23)03024-x.
- Tu1796 OUTCOMES OF ACCELERATED VS. STANDARD INFLIXIMAB INDUCTION DOSE IN CROHN'S DISEASEAlmomen H, Sayed A, Chipkin B, Nawaz A, Gaidos J, Proctor D, Bawardy B. Tu1796 OUTCOMES OF ACCELERATED VS. STANDARD INFLIXIMAB INDUCTION DOSE IN CROHN'S DISEASE. Gastroenterology 2023, 164: s-1132. DOI: 10.1016/s0016-5085(23)03611-9.
- 113 LONGER COLONOSCOPY WITHDRAWAL TIME IS ASSOCIATED WITH THE DETECTION OF POLYPOID DYSPLASIA IN INFLAMMATORY BOWEL DISEASEMcMillan C, Li D, Gaidos J, Proctor D, Bawardy B. 113 LONGER COLONOSCOPY WITHDRAWAL TIME IS ASSOCIATED WITH THE DETECTION OF POLYPOID DYSPLASIA IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2023, 164: s-16. DOI: 10.1016/s0016-5085(23)00993-9.
- Assessment of Inflammatory Bowel Disease Training Among Gastroenterology FellowsAl-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. Inflammatory Bowel Diseases 2023, 29: 1990-1992. PMID: 36810663, DOI: 10.1093/ibd/izad030.
- Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel diseaseSayed A, Assis D, Silveira M, Deng Y, Ciarleglio M, Gaidos J, Proctor D, Al-Bawardy B. Outcomes of immunomodulator and advanced therapies for primary sclerosing cholangitis-associated inflammatory bowel disease. European Journal Of Gastroenterology & Hepatology 2023, 35: 270-274. PMID: 36708297, DOI: 10.1097/meg.0000000000002510.
- A Practical Approach to IBD Care in the Pregnant PatientSahyoun L, Gaidos J. A Practical Approach to IBD Care in the Pregnant Patient. Current Gastroenterology Reports 2022, 24: 201-209. PMID: 36422770, DOI: 10.1007/s11894-022-00856-3.
- Burnout Among US Gastroenterologists and Fellows in TrainingAnderson J, Bilal M, Burke C, Gaidos J, Lopez R, Oxentenko A, Surawicz C. Burnout Among US Gastroenterologists and Fellows in Training. Journal Of Clinical Gastroenterology 2022, 57: 1063-1069. PMID: 36477385, DOI: 10.1097/mcg.0000000000001781.
- S856 Predictors of Colectomy in Acute Severe Ulcerative ColitisSharma S, Li D, Levine L, Chaar A, McMillan C, Gaidos J, Proctor D, Al-Bawardy B. S856 Predictors of Colectomy in Acute Severe Ulcerative Colitis. The American Journal Of Gastroenterology 2022, 117: e618-e619. DOI: 10.14309/01.ajg.0000860064.59694.03.
- S863 Impact of Race on ANTI-TNF Immunogenicity in Patients with Inflammatory Bowel DiseaseNawaz A, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. S863 Impact of Race on ANTI-TNF Immunogenicity in Patients with Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e623-e624. DOI: 10.14309/01.ajg.0000860092.19979.d5.
- S862 Rates and Outcomes of Histologic Healing in Crohn's DiseaseMcMillan C, Levine L, Gaidos J, Proctor D, Al-Bawardy B, Jain D, Liang Y. S862 Rates and Outcomes of Histologic Healing in Crohn's Disease. The American Journal Of Gastroenterology 2022, 117: e622-e623. DOI: 10.14309/01.ajg.0000860088.69814.32.
- S875 Assessment of Inflammatory Bowel Disease Training Among Gastroenterology FellowsAl-Bawardy B, Malter L, Ehrlich A, Rieder F, Gaidos J, Proctor D, Windish D. S875 Assessment of Inflammatory Bowel Disease Training Among Gastroenterology Fellows. The American Journal Of Gastroenterology 2022, 117: e632-e632. DOI: 10.14309/01.ajg.0000860140.96667.49.
- S1011 Inflammatory Bowel Disease Patients Commonly but Inconsistently Change Diet for FlaresShori C, Damianos J, DiVincenzo C, Ishola Y, Larson D, Burgermaster M, Gaidos J, Feagins L. S1011 Inflammatory Bowel Disease Patients Commonly but Inconsistently Change Diet for Flares. The American Journal Of Gastroenterology 2022, 117: e732-e733. DOI: 10.14309/01.ajg.0000860684.14143.a0.
- S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel DiseaseFeagins L, Moore P, Crabtree M, Lemay C, Loughlin A, Gaidos J. S883 Impact of Fatigue on Work Productivity and Activity Impairment and Health Care Utilization in Patients With Inflammatory Bowel Disease. The American Journal Of Gastroenterology 2022, 117: e639-e640. DOI: 10.14309/01.ajg.0000860172.94404.2d.
- S1013 Use of IBD Endoscopic Scoring Systems in PracticeGaidos J, Al-Bawardy B, Farraye F, Regueiro M. S1013 Use of IBD Endoscopic Scoring Systems in Practice. The American Journal Of Gastroenterology 2022, 117: e733-e734. DOI: 10.14309/01.ajg.0000860692.83055.c3.
- Tu1434: RETHINKING LOW FIBER DIETS FOR ACTIVE INFLAMMATORY BOWEL DISEASEDi Vincenzo C, Damianos J, Shori C, Ishola Y, Chebaa B, Koshar P, Burgermaster M, Gaidos J, Feagins L. Tu1434: RETHINKING LOW FIBER DIETS FOR ACTIVE INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s-958. DOI: 10.1016/s0016-5085(22)62272-8.
- Mo1547: IMPACT OF EARLY VS DELAYED FLEXIBLE SIGMOIDOSCOPY ON OUTCOMES IN INPATIENT SEVERE ULCERATIVE COLITISSharma S, Levine L, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Mo1547: IMPACT OF EARLY VS DELAYED FLEXIBLE SIGMOIDOSCOPY ON OUTCOMES IN INPATIENT SEVERE ULCERATIVE COLITIS. Gastroenterology 2022, 162: s-813. DOI: 10.1016/s0016-5085(22)61919-x.
- Tu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTSLevine L, Sharma S, McMillan C, Li D, Gaidos J, Proctor D, Bawardy B. Tu1429: FREQUENCY AND CHARACTERISTICS OF NUTRITION ASSESSMENT IN HOSPITALIZED ULCERATIVE COLITIS PATIENTS. Gastroenterology 2022, 162: s-957. DOI: 10.1016/s0016-5085(22)62267-4.
- PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBDSayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Gastroenterology 2022, 162: s76. DOI: 10.1053/j.gastro.2021.12.161.
- OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA)Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Gastroenterology 2022, 162: s75-s76. DOI: 10.1053/j.gastro.2021.12.160.
- IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASENawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2022, 162: s107-s108. DOI: 10.1053/j.gastro.2021.12.221.
- PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBDSayed A, Silveira M, Assis D, Deng Y, Gaidos J, Proctor D, Al-Bawardy B. PREDICTORS AND OUTCOMES OF BIOLOGIC/IMMUNOSUPPRESSIVE THERAPY FOR PSC-ASSOCIATED IBD. Inflammatory Bowel Diseases 2022, 28: s76-s76. DOI: 10.1093/ibd/izac015.124.
- OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA)Petrov J, Al-Bawardy B, Gaidos J, Proctor D. OUTCOMES OF TOTAL PROCTOCOLECTOMY (TPC) WITH ILEAL POUCH ANAL ANASTOMOSIS (IPAA). Inflammatory Bowel Diseases 2022, 28: s75-s76. DOI: 10.1093/ibd/izac015.123.
- IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASENawaz A, Glick L, Li D, Gaidos J, Proctor D, Al-Bawardy B. IMPACT OF THIOPURINE DOSE IN COMBINATION THERAPY IN INFLAMMATORY BOWEL DISEASE. Inflammatory Bowel Diseases 2022, 28: s107-s108. DOI: 10.1093/ibd/izac015.174.
- Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel diseaseNawaz A, Glick L, Chaar A, Li D, Gaidos J, Proctor D, Al-Bawardy B. Impact of thiopurine dose in anti-tumor necrosis factor combination therapy on outcomes in inflammatory bowel disease. Annals Of Gastroenterology 2022, 36: 39-44. PMID: 36593807, PMCID: PMC9756033, DOI: 10.20524/aog.2022.0766.
- Su465 EFFECT OF OBESITY ON VEDOLIZUMAB RESPONSE IN INFLAMMATORY BOWEL DISEASELevine L, Gaidos J, Proctor D, Viana A, Bawardy B. Su465 EFFECT OF OBESITY ON VEDOLIZUMAB RESPONSE IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703-s-704. DOI: 10.1016/s0016-5085(21)02387-8.
- Sa566 OUTCOMES OF INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ADVANCED LIVER FIBROSIS AND CIRRHOSISLi M, Khan S, Gaidos J, Proctor D, Bawardy B. Sa566 OUTCOMES OF INFLAMMATORY BOWEL DISEASE WITH CONCOMITANT ADVANCED LIVER FIBROSIS AND CIRRHOSIS. Gastroenterology 2021, 160: s-554. DOI: 10.1016/s0016-5085(21)02022-9.
- Su464 PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASELevine L, Gaidos J, Proctor D, Bawardy B. Su464 PREDICTORS AND OUTCOMES OF VEDOLIZUMAB DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE. Gastroenterology 2021, 160: s-703. DOI: 10.1016/s0016-5085(21)02386-6.
- THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSISLi M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Gastroenterology 2021, 160: s62. DOI: 10.1053/j.gastro.2021.01.159.
- THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSISLi M, Khan S, Proctor D, Gaidos J, Al-Bawardy B. THE SAFETY, TOLERABILITY, AND EFFECTIVENESS OF BIOLOGICS/SMALL MOLECULE THERAPY IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE AND CIRRHOSIS. Inflammatory Bowel Diseases 2021, 27: s45-s46. DOI: 10.1093/ibd/izaa347.110.
- Medication Adherence During Pregnancy in IBD: Compliance Avoids ComplicationsGaidos JKJ, Kane SV. Medication Adherence During Pregnancy in IBD: Compliance Avoids Complications. Digestive Diseases And Sciences 2020, 66: 336-337. PMID: 32323073, DOI: 10.1007/s10620-020-06271-w.
- Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based SurveyMalter L, Jain A, Cohen BL, Gaidos JKJ, Axisa L, Butterfield L, Rescola BJ, Sarode S, Ehrlich O, Cheifetz AS. Identifying IBD Providers’ Knowledge Gaps Using a Prospective Web-based Survey. Inflammatory Bowel Diseases 2020, 26: 1445-1450. PMID: 32100018, DOI: 10.1093/ibd/izaa032.
- High Prevalence of Male Sexual Dysfunction in a Prospective Multicenter VA Inflammatory Bowel Disease PopulationGaidos J, Naik K, Dave J, Yao M, Hou J, Cipher D, Smith A, Feagins L. High Prevalence of Male Sexual Dysfunction in a Prospective Multicenter VA Inflammatory Bowel Disease Population. Crohn's & Colitis 360 2020, 2: otaa004. PMID: 36777954, PMCID: PMC9801960, DOI: 10.1093/crocol/otaa004.
- The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel DiseaseThakur ER, Sansgiry S, Kramer JR, Waljee AK, Gaidos JK, Feagins LA, Govani SM, Dindo L, El-Serag HB, Hou JK. The Incidence and Prevalence of Anxiety, Depression, and Post-traumatic Stress Disorder in a National Cohort of US Veterans With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2019, 26: 1423-1428. PMID: 31728520, PMCID: PMC7441098, DOI: 10.1093/ibd/izz280.
- 515 Are All Endoscopic-Related Musculoskeletal Injuries Created Equal?: Results of a National Gender-Based SurveyPawa S, Banerjee P, Kothari S, D'Souza S, Martindale S, Gaidos J, Oxentenko A, Burke C. 515 Are All Endoscopic-Related Musculoskeletal Injuries Created Equal?: Results of a National Gender-Based Survey. The American Journal Of Gastroenterology 2019, 114: s299-s299. DOI: 10.14309/01.ajg.0000591592.66925.e8.
- Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy.Feagins LA, Kim J, Chandrakumaran A, Gandle C, Naik KH, Cipher DJ, Hou JK, Yao MD, Gaidos JKJ. Rates of Adverse IBD-Related Outcomes for Patients With IBD and Concomitant Prostate Cancer Treated With Radiation Therapy. Inflammatory Bowel Diseases 2019, 26: 728-733. PMID: 31412114, DOI: 10.1093/ibd/izz175.
- Sa1782 – Effect of Vaccination and Immunosuppressive Medications on Invasive Pneumococcal Disease Occurrence in Veterans with Inflammatory Bowel DiseaseLove B, Finney C, Gaidos J. Sa1782 – Effect of Vaccination and Immunosuppressive Medications on Invasive Pneumococcal Disease Occurrence in Veterans with Inflammatory Bowel Disease. Gastroenterology 2019, 156: s-400. DOI: 10.1016/s0016-5085(19)37849-7.
- Mo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation TherapyFeagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. Mo1862 – No Increaed Rates of Adverse Ibd-Related Outcomes for Patients with IBD and Concomitant Prostate Cancer Treated with Radiation Therapy. Gastroenterology 2019, 156: s-867. DOI: 10.1016/s0016-5085(19)39129-2.
- 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASESMalter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Inflammatory Bowel Diseases 2019, 25: s1-s1. DOI: 10.1093/ibd/izy393.001.
- P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPYFeagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Inflammatory Bowel Diseases 2019, 25: s34-s34. DOI: 10.1093/ibd/izy393.078.
- P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPYFeagins L, Kim J, Chandrakumaran A, Gandle C, Naik K, Hou J, Yao M, Gaidos J. P071 NO INCREASED RATE OF ADVERSE IBD-RELATED OUTCOMES FOR PATIENTS WITH IBD AND CONCURRENT PROSTATE CANCER TREATED WITH RADIATION THERAPY. Gastroenterology 2019, 156: s49-s50. DOI: 10.1053/j.gastro.2019.01.130.
- 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASESMalter L, Jain A, Cohen B, Gaidos J, Axisa L, Butterfield L, Rescola B, Sarode S, Cheifetz A, Ehrlich O. 18 CLINICAL PRACTITIONERS’ EDUCATION AND RESOURCE NEEDS FOR INFLAMMATORY BOWEL DISEASES. Gastroenterology 2019, 156: s1-s2. DOI: 10.1053/j.gastro.2019.01.045.
- Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record SystemValluru N, Kang L, Gaidos JKJ. Health Maintenance Documentation Improves for Veterans with IBD Using a Template in the Computerized Patient Record System. Digestive Diseases And Sciences 2018, 63: 1782-1786. PMID: 29736836, DOI: 10.1007/s10620-018-5093-5.
- Mo1812 - Prevalence and Risk Factors for Male Sexual Dysfunction in a Prospective Multicenter Va Inflammatory Bowel Disease PopulationGaidos J, Herbst K, Dave J, Yao M, Hou J, Smith A, Feagins L. Mo1812 - Prevalence and Risk Factors for Male Sexual Dysfunction in a Prospective Multicenter Va Inflammatory Bowel Disease Population. Gastroenterology 2018, 154: s-811. DOI: 10.1016/s0016-5085(18)32776-8.
- P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEWGovani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Inflammatory Bowel Diseases 2018, 24: s5-s5. DOI: 10.1093/ibd/izy019.010.
- P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTSHerbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Inflammatory Bowel Diseases 2018, 24: s22-s22. DOI: 10.1093/ibd/izy019.064.
- P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTSHerbst K, Kang L, Gaidos J. P058 INCREASES IN HEMOGLOBIN ARE ASSOCIATED WITH A DECREASED RISK FOR COLORECTAL CANCER IN VETERAN’S AFFAIRS INFLAMMATORY BOWEL DISEASE PATIENTS. Gastroenterology 2018, 154: s31. DOI: 10.1053/j.gastro.2017.11.096.
- P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEWGovani S, Millien V, Ali S, Dave J, Hou J, Gaidos J, Yao M, Feagins L, Velligan D, Pugh J, Waljee A. P010 ADHERENCE TO INFLIXIMAB FOR INFLAMMATORY BOWEL DISEASE, A MULTICENTER RETROSPECTIVE REVIEW. Gastroenterology 2018, 154: s6-s7. DOI: 10.1053/j.gastro.2017.11.042.
- Gender Disparities in the Professional and Personal Lives of Gastroenterologists: A Nationwide SurveyBurke C, Lopez R, Oxentenko A, Gaidos J, Surawicz C. Gender Disparities in the Professional and Personal Lives of Gastroenterologists: A Nationwide Survey. The American Journal Of Gastroenterology 2017, 112: s613-s614. DOI: 10.14309/00000434-201710001-01122.
- Biologics in Pregnancy and BreastfeedingGaidos J, Kane S. Biologics in Pregnancy and Breastfeeding. 2017, 81-99. DOI: 10.1007/978-3-319-60276-9_6.
- Sexuality, Fertility, and Pregnancy in Crohn's DiseaseGaidos J, Kane S. Sexuality, Fertility, and Pregnancy in Crohn's Disease. Gastroenterology Clinics Of North America 2017, 46: 531-546. PMID: 28838413, DOI: 10.1016/j.gtc.2017.05.007.
- Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel DiseaseFeagins LA, Waljee A, Hou JK, Gu P, Kanjo S, Rudrapatna V, Cipher DJ, Govani S, Gaidos J. Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2017, 23: 1434-1439. PMID: 28570429, DOI: 10.1097/mib.0000000000001145.
- Mo1811 Improving Health Maintenance in Veterans with Inflammatory Bowel Disease Using a Template in the Computerized Patient Record SystemValluru N, Gaidos J. Mo1811 Improving Health Maintenance in Veterans with Inflammatory Bowel Disease Using a Template in the Computerized Patient Record System. Gastroenterology 2017, 152: s787-s788. DOI: 10.1016/s0016-5085(17)32730-0.
- Increased Prevalence of NAFLD in IBD PatientsGaidos JKJ, Fuchs M. Increased Prevalence of NAFLD in IBD Patients. Digestive Diseases And Sciences 2017, 62: 1362-1362. PMID: 28357696, DOI: 10.1007/s10620-017-4552-8.
- Managing IBD Therapies in PregnancyGaidos JK, Kane SV. Managing IBD Therapies in Pregnancy. Current Treatment Options In Gastroenterology 2017, 15: 71-83. PMID: 28181180, DOI: 10.1007/s11938-017-0123-5.
- How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease PatientsGaidos JK, Bickston SJ. How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients. Inflammatory Bowel Diseases 2016, 22: 1219-1230. PMID: 26926040, DOI: 10.1097/mib.0000000000000685.
- Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease PatientsAlsaleh A, Gaidos JK, Kang L, Kuemmerle JF. Timing of Last Preoperative Dose of Infliximab Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. Digestive Diseases And Sciences 2016, 61: 2602-2607. PMID: 27126205, PMCID: PMC4982818, DOI: 10.1007/s10620-016-4171-9.
- Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel DiseaseFeagins L, Waljee A, Hou J, Gu P, Kanjo S, Rudrapatna V, Ellis A, Govani S, Gaidos J. Sa1885 Incidence of and Predictors for Early Discontinuation of Biologic Therapies in Veteran Patients with Inflammatory Bowel Disease. Gastroenterology 2016, 150: s392. DOI: 10.1016/s0016-5085(16)31374-9.
- Su1842 The Incidence and Prevalence of Anxiety, Depression, and PTSD Among a National Cohort of U.S. Veterans With Inflammatory Bowel DiseaseThakur E, Waljee A, Gaidos J, Feagins L, Govani S, Sansgiry S, Kramer J, Dindo L, El-Serag H, Hou J. Su1842 The Incidence and Prevalence of Anxiety, Depression, and PTSD Among a National Cohort of U.S. Veterans With Inflammatory Bowel Disease. Gastroenterology 2016, 150: s567. DOI: 10.1016/s0016-5085(16)31941-2.
- Su1833 Colorectal Cancer Is Diagnosed Earlier After Inflammatory Bowel Disease Diagnosis in African Americans Compared to Whites: A National Cohort StudyZhang H, Panara A, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1833 Colorectal Cancer Is Diagnosed Earlier After Inflammatory Bowel Disease Diagnosis in African Americans Compared to Whites: A National Cohort Study. Gastroenterology 2016, 150: s565. DOI: 10.1016/s0016-5085(16)31932-1.
- Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort StudyPanara A, Zhang H, Waljee A, Gaidos J, Feagins L, Govani S, Thrift A, El-Serag H, Hou J. Su1816 Presence of Colonic Dysplasia prior to Colorectal Cancer Diagnosis is Associated with Early Stage Cancer among Patients with Inflammatory Bowel Disease: A National Cohort Study. Gastroenterology 2016, 150: s561. DOI: 10.1016/s0016-5085(16)31915-1.
- Su1904 Role of the Gut Microbiome in Acute Graft Versus Host Disease: A Pilot StudyGaidos J, Toor A, Roberts C, Chung H, Clark W, McCarty J, Sanyal A. Su1904 Role of the Gut Microbiome in Acute Graft Versus Host Disease: A Pilot Study. Gastroenterology 2016, 150: s584. DOI: 10.1016/s0016-5085(16)32003-0.
- Overcoming challenges of treating inflammatory bowel disease in pregnancyGaidos JK, Kane SV. Overcoming challenges of treating inflammatory bowel disease in pregnancy. Expert Review Of Clinical Immunology 2016, 12: 871-878. PMID: 26981845, DOI: 10.1586/1744666x.2016.1166958.
- Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease PatientsGaidos J, Alsaleh A, Kuemmerle J. Timing of Last Preoperative Dose of Anti-Tumor Necrosis Factor α Does Not Increase Postoperative Complications in Inflammatory Bowel Disease Patients. The American Journal Of Gastroenterology 2015, 110: s797. DOI: 10.14309/00000434-201510001-01877.
- A case of infectious mononucleosis in a patient with ulcerative colitis on infliximabBien A, Banks K, Gaidos J, Kuemmerle J. A case of infectious mononucleosis in a patient with ulcerative colitis on infliximab. Case Reports In Internal Medicine 2014, 1 DOI: 10.5430/crim.v1n2p202.
- A Case of Infectious Mononucleosis in a Patient with Ulcerative Colitis on InfliximabBien A, Gaidos J, Kuemmerle J, Banks K. A Case of Infectious Mononucleosis in a Patient with Ulcerative Colitis on Infliximab. The American Journal Of Gastroenterology 2012, 107: s505. DOI: 10.14309/00000434-201210001-01271.
- Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleedingWilliamson JB, Judah JR, Gaidos JK, Collins DP, Wagh MS, Chauhan SS, Zoeb S, Buscaglia JM, Yan H, Hou W, Draganov PV. Prospective evaluation of the long-term outcomes after deep small-bowel spiral enteroscopy in patients with obscure GI bleeding. Gastrointestinal Endoscopy 2012, 76: 771-778. PMID: 22771101, DOI: 10.1016/j.gie.2012.05.025.
- Long-Term Outcomes after Deep Small Bowel Spiral Enteroscopy for Evaluation of Obscure Gastrointestinal (GI) BleedingWilliamson J, Zoeb S, Buscaglia J, Gaidos J, Judah J, Collins D, Draganov P. Long-Term Outcomes after Deep Small Bowel Spiral Enteroscopy for Evaluation of Obscure Gastrointestinal (GI) Bleeding. The American Journal Of Gastroenterology 2011, 106: s547. DOI: 10.14309/00000434-201110002-01430.
- Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patientsNagula S, Gaidos J, Draganov PV, Bucobo JC, Cho B, Hernandez Y, Buscaglia JM. Retrograde spiral enteroscopy: feasibility, success, and safety in a series of 22 patients. Gastrointestinal Endoscopy 2011, 74: 699-702. PMID: 21762908, DOI: 10.1016/j.gie.2011.05.017.
- Does BMI Influence the Development of Hepatotoxicity in Patients With Inflammatory Bowel Disease (IBD) and Elevated 6MMP Levels?Alsaleh A, Gaidos J, Valentine J. Does BMI Influence the Development of Hepatotoxicity in Patients With Inflammatory Bowel Disease (IBD) and Elevated 6MMP Levels? Gastroenterology 2011, 140: s-772. DOI: 10.1016/s0016-5085(11)63202-2.
- Prospective Evaluation of the Clinical Utility of Spiral Deep Small Bowel Enteroscopy (SBE) in Patients with Known or Suspected Crohnʼs Disease (CD)Gaidos J, Judah J, Collins D, Draganov P. Prospective Evaluation of the Clinical Utility of Spiral Deep Small Bowel Enteroscopy (SBE) in Patients with Known or Suspected Crohnʼs Disease (CD). The American Journal Of Gastroenterology 2010, 105: s422. DOI: 10.14309/00000434-201010001-01163.
- Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel EnteroscopyJudah JR, Collins D, Gaidos JK, Hou W, Forsmark CE, Draganov PV. Prospective Evaluation of Gastroenterologist-Guided, Nurse-Administered Standard Sedation for Spiral Deep Small Bowel Enteroscopy. Digestive Diseases And Sciences 2010, 55: 2584-2591. PMID: 20632098, DOI: 10.1007/s10620-010-1335-x.
- Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents.Gaidos JK, Draganov PV. Treatment of malignant gastric outlet obstruction with endoscopically placed self-expandable metal stents. World Journal Of Gastroenterology 2009, 15: 4365-71. PMID: 19764086, PMCID: PMC2747055, DOI: 10.3748/wjg.15.4365.
- A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitisGaidos JK, Hillner BE, Sanyal AJ. A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver International 2008, 28: 650-658. PMID: 18331241, DOI: 10.1111/j.1478-3231.2008.01693.x.
Clinical Trials
| Conditions | Study Title |
|---|---|
| Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease |
| Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum; Diseases of the Digestive System - Stomach | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease |
| Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease |
| Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum | The OPTIMIZE Trial |